Copyright
©The Author(s) 2020.
World J Gastroenterol. Feb 7, 2020; 26(5): 478-498
Published online Feb 7, 2020. doi: 10.3748/wjg.v26.i5.478
Published online Feb 7, 2020. doi: 10.3748/wjg.v26.i5.478
Sex/age in yr | Tissue | Diagnosis | Duration in yr | Treatment |
F/18 | Colon | CD (active) | 1 | 5-ASA + prednisone |
M/21 | Ileum | CD (active) | 5 | Infliximab + azathioprine |
F/35 | Ileum | CD (active) | 10 | Infliximab + prednisone |
F/37 | Colon | CD (active) | 6 | Prednisone |
M/50 | Colon | CD (active) | 16 | Infliximab + azathioprine |
M/23 | Colon | CD (active) | 3 | Prednisone |
F/28 | Colon | CD (active) | 4 | 5-ASA + prednisone |
M/19 | Colon | CD (active) | 1 | 5-ASA |
M/22 | Ileum | CD (active) | 3 | 5-ASA + prednisone |
M/31 | Colon | CD (active) | 5 | Prednisone |
F/24 | Colon | CD (active) | 10 | Infliximab + prednisone |
M/49 | Ileum | CD (active) | 15 | Infliximab + azathioprine |
M/22 | Ileum | CD (active) | 3 | 5-ASA + prednisone |
M/24 | Colon | CD (active) | 2 | 5-ASA + prednisone |
F/15 | Colon | CD (active) | 1 | 5-ASA |
F/42 | Ileum | CD (active) | 20 | Infliximab + azathioprine |
M/32 | Ileum | CD (active) | 5 | 5-ASA + azathioprine |
M/40 | Ileum | CD (active) | 5 | 5-ASA + prednisone |
F/33 | Colon | CD (active) | 7 | Infliximab + prednisone |
M/35 | Ileum | CD (active) | 3 | Azathioprine |
M/36 | Ileum | CD (active) | 5 | Azathioprine |
F/28 | Ileum | CD (active) | 4 | Azathioprine |
F/33 | Colon | CD (active) | 5 | 5-ASA + azathioprine |
F/50 | Ileum | CD (active) | Prednisone | |
F/45 | Ileum | CD (active) | Azathioprine | |
M/37 | Colon | CD (active) | 6 | Infliximab + prednisone |
M/43 | Colon | CD (active) | 16 | Infliximab + prednisone |
M/22 | Colon | CD (active) | 4 | Infliximab + azathioprine |
M/18 | Colon | CD (active) | 2 | Infliximab + prednisone |
M/15 | Colon | CD (active) | 5 | Infliximab + azathioprine |
F/52 | Colon | CD (active) | 10 | Infliximab + prednisone |
M/23 | Colon | CD (active) | 4 | 5-ASA + prednisone |
M/45 | Ileum | CD (active) | 3 | 5-ASA |
F/23 | Colon | CD (active) | 4 | 5-ASA + prednisone |
F/33 | Colon | CD (active) | 5 | Prednisone |
F/39 | Colon | CD (active) | 6 | Infliximab + prednisone |
F/29 | Colon | CD (active) | 9 | Infliximab + azathioprine |
F/14 | Ileum | CD (active) | 1 | 5-ASA+ prednisone |
F/23 | Colon | CD (active) | 6 | Azathioprine |
F/49 | Colon | CD (active) | 15 | Infliximab + azathioprine |
F/45 | Ileum | NC | 0 | NA |
M/37 | Ileum | NC | 0 | NA |
M/39 | Colon | NC | 0 | NA |
M/22 | Ileum | NC | 0 | NA |
M/22 | Colon | NC | 0 | NA |
M/15 | Ileum | NC | 0 | NA |
F/49 | Colon | NC | 0 | NA |
M/23 | Ileum | NC | 0 | NA |
M/40 | Ileum | NC | 0 | NA |
F/23 | Colon | NC | 0 | NA |
F/39 | Colon | NC | 0 | NA |
F/43 | Colon | NC | 0 | NA |
M/25 | Colon | NC | 0 | NA |
M/27 | Ileum | NC | 0 | NA |
F/15 | Colon | NC | 0 | NA |
F/23 | Colon | NC | 0 | NA |
M/32 | Colon | NC | 0 | NA |
M/10 | Colon | NC | 0 | NA |
F/33 | Colon | NC | 0 | NA |
M/35 | Ileum | NC | 0 | NA |
M/37 | Colon | NC | 0 | NA |
F/28 | Colon | NC | 0 | NA |
F/33 | Ileum | NC | 0 | NA |
F/50 | Ileum | NC | 0 | NA |
F/45 | Colon | NC | 0 | NA |
M/37 | Colon | NC | 0 | NA |
M/42 | Colon | NC | 0 | NA |
M/22 | Ileum | NC | 0 | NA |
M/18 | Colon | NC | 0 | NA |
M/15 | Colon | NC | 0 | NA |
F/52 | Ileum | NC | 0 | NA |
M/23 | Ileum | NC | 0 | NA |
M/42 | Ileum | NC | 0 | NA |
F/23 | Colon | NC | 0 | NA |
F/35 | Colon | NC | 0 | NA |
F/35 | Ileum | NC | 0 | NA |
M/29 | Colon | NC | 0 | NA |
F/14 | Ileum | NC | 0 | NA |
F/23 | Ileum | NC | 0 | NA |
M/42 | Ileum | NC | 0 | NA |
- Citation: Li N, Shi RH. lncRNACNN3-206 activates intestinal epithelial cell apoptosis and invasion by sponging miR-212, an implication for Crohn's disease. World J Gastroenterol 2020; 26(5): 478-498
- URL: https://www.wjgnet.com/1007-9327/full/v26/i5/478.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i5.478